University of Maryland Medical Center – Methadone Program provides drug and alcohol treatment from its location at 1001 West Pratt Street in Baltimore, Maryland. It is a nonprofit provider.
Its services include medically supervised detox, standard outpatient counseling, medication-assisted treatment (MAT), a federally certified opioid treatment program (methadone), co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and motivational interviewing. For opioid use disorder, the program uses methadone, buprenorphine, and naltrexone. It also prescribes medication for alcohol use disorder.
Payment options include government funding for people who qualify, Medicare, Medicaid, private health insurance, cash or self-payment, and state-financed health insurance. Payment assistance is available; ask the facility for details. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for women, men, clients with co-occurring mental and substance use disorders, and clients with co-occurring pain and substance use disorders.
University of Maryland Medical Center – Methadone Program is accredited by CARF and National Committee for Quality Assurance (NCQA) and licensed or certified by the state substance use treatment agency, state mental health department, state department of health, and SAMHSA certification for opioid treatment program (OTP).